𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging

✍ Scribed by Emma J. Burton; Ian G. McKeith; David J. Burn; John T. O'Brien


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
76 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Increased rates of brain atrophy are seen in Alzheimer's disease, but whether rates are similarly increased in other dementias such as Parkinson's disease dementia (PDD) has not been well examined. We determined the rates of brain atrophy using serial magnetic resonance imaging (MRI) in PDD and compared this finding to rates seen in cognitively intact Parkinson's disease (PD) patients and age‐matched control subjects. Thirty‐one patients (PD = 18, PDD = 13) and 24 age‐matched controls underwent serial volumetric 1.5 T MRI scans, approximately 1 year apart. Baseline and repeat scans were registered and quantification of the brain boundary shift integral was used to determine whole‐brain atrophy rates. Rates of brain atrophy were significantly increased in PDD (1.12 ± 0.98%/year) compared to PD (0.31 ± 0.69%/year; P = 0.018) and control subjects (0.34 ± 0.76%/year; P = 0.015). There were no differences in atrophy rates between controls and PD (P = 0.79). No correlations between increased atrophy rates and age or dementia severity (Mini‐Mental State Examination score) were observed. Serial MRI may be a useful tool for monitoring disease progression in PDD and further studies should investigate its utility for early diagnosis. © 2005 Movement Disorder Society


📜 SIMILAR VOLUMES


Ventricular dilatation and brain atrophy
✍ Richard Camicioli; Jennifer Sabino; Myrlene Gee; Thomas Bouchard; Nancy Fisher; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

## Abstract Age‐related ventricular enlargement is accelerated in Alzheimer's disease, but its relationship to cognitive decline in Parkinson's disease is less clear, even though dementia is common in Parkinson's disease. Our goals were to determine if greater enlargement of the ventricles and gray

Performing functional magnetic resonance
✍ Paula R. Arantes; Ellison F. Cardoso; Maria Â. Barreiros; Manoel J. Teixeira; Má 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Deep brain stimulation (DBS) is a relatively novel treatment in advanced Parkinson's disease (PD). Functional magnetic resonance imaging (fMRI) is a useful technique for examining the effects of DBS both within the basal ganglia and its cortical connectivity. There are technical difficulties in imag